PillRx only · Injection, Solution · Subcutaneous
Insulin Aspart Injection
Brands: Fiasp · Insulin Aspart
1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US3 NDCs
1 active makers
1 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$8.122
Latest avg · Jul 22, 2026
-75%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*